Detalhe da pesquisa
1.
Calendar-period trends in cervical precancer and cancer diagnoses since the introduction of human papillomavirus and cytology co-testing into routine cervical cancer screening at Kaiser Permanente Northern California.
Gynecol Oncol;
184: 89-95, 2024 Jan 31.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38301311
2.
Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States.
Int J Cancer;
153(1): 83-93, 2023 07 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36946690
3.
Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States.
Gynecol Oncol;
162(3): 555-559, 2021 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34253387
4.
Absolute risks of cervical precancer among women who fulfill exiting guidelines based on HPV and cytology cotesting.
Int J Cancer;
146(3): 617-626, 2020 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30861114
5.
A study of the risks of CIN3+ detection after multiple rounds of HPV testing: Results of the 15-year cervical cancer screening experience at Kaiser Permanente Northern California.
Int J Cancer;
147(6): 1612-1620, 2020 09 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32141607
6.
Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines.
J Low Genit Tract Dis;
24(2): 132-143, 2020 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32243308
7.
Impact of human papillomavirus vaccination on the clinical meaning of cervical screening results.
Prev Med;
118: 44-50, 2019 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30316878
8.
Effect of Several Negative Rounds of Human Papillomavirus and Cytology Co-testing on Safety Against Cervical Cancer: An Observational Cohort Study.
Ann Intern Med;
168(1): 20-29, 2018 01 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29181509
9.
Adherence patterns to extended cervical screening intervals in women undergoing human papillomavirus (HPV) and cytology cotesting.
Prev Med;
109: 44-50, 2018 04.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29288782
10.
Challenges in risk estimation using routinely collected clinical data: The example of estimating cervical cancer risks from electronic health-records.
Prev Med;
111: 429-435, 2018 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29222045
11.
Low Risk of Cervical Cancer/Precancer Among Most Women Under Surveillance Postcolposcopy.
J Low Genit Tract Dis;
22(2): 97-103, 2018 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29570564
12.
Why does cervical cancer occur in a state-of-the-art screening program?
Gynecol Oncol;
146(3): 546-553, 2017 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28606721
13.
Protection against cervical cancer versus decreasing harms from screening - What would U.S. patients and clinicians prefer, and do their preferences matter?
Prev Med;
98: 31-32, 2017 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28279259
14.
Risks of CIN 2+, CIN 3+, and Cancer by Cytology and Human Papillomavirus Status: The Foundation of Risk-Based Cervical Screening Guidelines.
J Low Genit Tract Dis;
21(4): 261-267, 2017 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-28953116
15.
The population impact of human papillomavirus/cytology cervical cotesting at 3-year intervals: Reduced cervical cancer risk and decreased yield of precancer per screen.
Cancer;
122(23): 3682-3686, 2016 Dec 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27657992
16.
A common clinical dilemma: Management of abnormal vaginal cytology and human papillomavirus test results.
Gynecol Oncol;
141(2): 364-370, 2016 05.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26915529
17.
A Common Clinical Dilemma: Management of Abnormal Vaginal Cytology and Human Papillomavirus Test Results.
J Low Genit Tract Dis;
20(2): 119-25, 2016 Apr.
Artigo
em Inglês
| MEDLINE
| ID: mdl-26901279
18.
Age-stratified 5-year risks of cervical precancer among women with enrollment and newly detected HPV infection.
Int J Cancer;
136(7): 1665-71, 2015 Apr 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25136967
19.
Human papillomavirus testing 2007-2012: co-testing and triage utilization and impact on subsequent clinical management.
Int J Cancer;
136(12): 2854-63, 2015 Jun 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25447979
20.
Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.
Gynecol Oncol;
136(2): 178-82, 2015 Feb.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25579107